Initial Therapeutics
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
285 E Grand Ave, South San Francisco, Ca...Website
www.initialtx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
2
1
1
About Initial Therapeutics
Initial Therapeutics is an ATP company that is discovering and developing a new class of small-molecule medicines designed to prevent pathogenic protein synthesis. The company is based in South San Francisco, California.Explore more
Initial Therapeutics Org Chart
BB
Scientist
SS
Scientist I - Computational Biology
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Initial Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Initial Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Initial Therapeutics recently announced quarterly report
Initial Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Initial Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Initial Therapeutics
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Initial Therapeutics has new funding data
Click to see if Initial Therapeutics had a recent Job posting/layoffs
Check if Initial Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Initial Therapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Initial Therapeutics
Compare insights from companies similar to Initial Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Initial Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Initial Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Initial Therapeutics.
Initial Therapeutics financials insights
Gather financial insights about Initial Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series A
$75M
Initial Therapeutics Tech Stack
A closer look at the technologies used by Initial Therapeutics
Most Recent Scoops
Lateral Move
Executive Move
Executive Moves, Lateral Move, Board of Directors
New Hire
Executive Move
Executive Moves, New Hire, Board of Directors
Funding
Funding
Initial Therapeutics News & Media
With $75 Million from Apple Tree Partners, Initial Therapeutics Launches to Create a New Kind of Drug Designed to Stop the Formation of Difficult-to-Drug Protein Targets
Initial was created to take on undruggable disease-causing proteins by discriminately intercepting their translation in the exit tunnel of the ribosome Initial's platform brings together scientific breakthroughs from the labs of Jamie H.D. Cate, Brian Paegel, and Kevan Shokat Company's...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Initial Therapeutics
Sign Up For FreeTo access detailed company insights
Initial Therapeutics is an ATP company that is discovering and developing a new class of small-molecule medicines designed to prevent pathogenic protein synthesis. The company is based in South San Francisco, California.... Read More
